Please login to the form below

Not currently logged in
Email:
Password:

Bayer wins FDA approval for MS electronic autoinjector and app

US regulator gives green light to Betaconnect and myBETA app

Bayer

The FDA has approved Bayer’s electronic autoinjector Betaconnect and associated myBETA app for multiple sclerosis patients to use.

The app - created by Medicom Innovation Partner - uses Bluetooth technology to connect with the autoinjector that administers Betaseron (interferon beta-1b), so patients can access and share their data with healthcare professionals via a mobile phone or computer.

“Since introducing the first FDA approved treatment option for relapsing remitting multiple sclerosis patients more than two decades ago, we’ve listened closely to the community to understand their needs and how we can support them,” said Mark Rametta, Bayer’s medical director for Neurology.

The app and the Betaconnect navigator also includes around-the-clock access to nurse support.

Patients using other injection methods to take Betaseron can also manually enter injection information into the app and can participate in sharing their data with their healthcare team.

The myBETA app will be available for free download at the Apple store, Google Play or Betaseron.com in mid-July.

Article by
Gemma Jones

19th June 2017

From: Marketing, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics